Navigation Links
New compound could reverse loss of muscle mass in cancer and other diseases
Date:12/19/2013

A new antibody could dramatically boost strength and muscle mass in patients with cancer, chronic obstructive pulmonary disease (COPD), sporadic inclusion body myositis, and in elderly patients with sarcopenia according to research published ahead of print in the journal Molecular and Cellular Biology.

"Age-related loss of muscle mass is a major contributing factor to falls, broken bones, and the loss of mobility," says co-corresponding author David Glass of Novartis, Cambridge, MA, one of the compound's developers, along with first author Estelle Trifilieff, also of Novartis. "This study illustrates that we may have a powerful tool to prevent muscle wasting and promote growth."

The new compound (BYM338) acts to prevent muscle wasting by blocking a receptor that engages a cellular signaling system that exists to put the brakes on muscle development when appropriate. But sometimes those brakes are activated inappropriately, or are stuck on.

"Our goal was to release the brakes," says Glass.

A variety of signals can activate the receptor. Prior to development of BYM338, compounds developed to block these molecules were blunt instruments, either trapping all incoming signals (which stimulated muscle growth but also caused harmful side effects) or blocking just a single receptor activator (providing only tepid growth stimulation.) BYM338 was designed to be in the Goldilocks zone (just right.)

In the study the compound boosted muscle mass 25 to 50 percent and increased strength in animal models. Those gains were significantly superior to those of compounds that blocked a single receptor activator. Clinical trials are currently underway.

The conditions BYM338 is designed to treat are losses of skeletal muscle and fat, which are not reversed by simply eating more, and are known as cachexias when associated with certain chronic illnesses. Cancer cachexia develops in a majority of patients with advanced
'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Canadian girl, 16, invents disease-fighting, anti-aging compound using tree particles
2. Biosensor illuminates compounds to aid fight against TB
3. New screening technique yields elusive compounds to block immune-regulating enzyme
4. Sulphur and iron compounds common in old shipwrecks
5. Heparin-like compounds inhibit breast cancer metastasis to bone
6. Like curry? New biological role identified for compound used in ancient medicine
7. Nuisance seaweed found to produce compounds with biomedical potential
8. Dont feel like exercise? Scientists find compound that may help you work out harder
9. New drug-screening method yields long-sought anti-HIV compounds
10. Nonstoichiometric Compounds V - An ECI Conference Series
11. New compound holds promise for treating Duchenne MD, other inherited diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... JOLLAJoseph Ecker, a Salk professor and Howard Hughes ... scientist, have been named recipients in the 2014 ... Health (NIH) through the BRAIN (Brain Research through ... neuroscience. The grant, announced September 30, provides more ... scientists over three years. , The BRAIN Initiative, ...
(Date:9/30/2014)... news release is available in German . ... are among the most expensive foods in the world. Because ... find them. But the distinctive smell of truffles is not ... French scientists under the direction of the Goethe University Frankfurt ... produced by soil bacteria which are trapped inside truffle fruiting ...
(Date:9/30/2014)... IVF? Here,s some hope: A new research report published ... Journal , explains how scientists developed a synthetic ... induced embryo development in human and mouse eggs similar ... sperm cell during fertilization. , "We believe that the ... in our understanding of human fertilization by providing a ...
Breaking Biology News(10 mins):Salk scientists receive $3 million for BRAIN Initiative grant 2On the trail of the truffle flavor 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2
... new organsreplacement hearts, lungs and kidneysis the difficulty researchers ... alive, but new findings from the University of Michigan ... enough to make a piece of tissue that functions ... professor of biomedical engineering. "If you don,t nourish it ...
... University of Notre Dame, The Nature Conservancy, and Central Michigan ... Great Lakes in a study published in the Canadian ... news is that we have found no evidence that Asian ... surveys in Southern Lake Michigan and parts of lakes Erie ...
... MANHATTAN, KAN. -- Kansas State University doctoral student Clint ... a student and his research developing new semiconductors. ... named a Lawrence scholar by Lawrence Livermore National Laboratory ... of the prestigious award and one of 12 scholars ...
Cached Biology News:Building better blood vessels could advance tissue engineering 2Building better blood vessels could advance tissue engineering 3Asian carp DNA not widespread in the Great Lakes 2Student named university's first Lawrence scholar, researching at national laboratory 2
(Date:9/30/2014)... CORALVILLE, Iowa , Sept. 30, 2014 /PRNewswire/ ... in the discovery and development of proprietary new ... United States Patent and Trademark Office (USPTO) issued ... patent application entitled, "Benzoic Acid, Benzoic Acid Derivatives ... Methods of Making and Use Thereof." ...
(Date:9/30/2014)... iLab Solutions announced the results of its ... on core facility operations, growth and utilization as well ... In its 4th year running, a number of long-term ... decrease in the percentage of revenue that comes from ... constraints of this trend. When asked, “What are your ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Lyme ... funder of Lyme disease research at universities, today announced ... focused on the identification, treatment and cure for Lyme ... had received the most applications in its history—over 20 ... , “While we were pleased to receive so many ...
(Date:9/30/2014)... September 30, 2014 On September 11, Pharma ... Sherley in anticipation of a session that he will lead ... Summit,” scheduled for February 17-18, 2015 in London. In ... IQ asked Dr. Sherley to respond to several questions on ... challenges to evaluating stem cell toxicity, and future trends in ...
Breaking Biology Technology:KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 2Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 4
... Nanoscience Center (NSC) of the University of Jyvskyl (Dr ... structural, electronic and optical properties of a chiral gold ... theoretical structure was confirmed via comparison to experimental results ... pure cluster material. The theoretical work was done in ...
... products in North America , ... TSX VENTURE: HTL , , , ... May 27 /PRNewswire-FirstCall/ - Hamilton Thorne Ltd. (TSX-V: HTL), a leading ... fertility clinic markets, today announces a vendor partnership agreement with Leica Microsystems GmbH ...
... 27 Pfizer Inc. (NYSE: PFE ) announced ... on the recommendations of the trial,s independent Executive Steering Committee (ESC). ... Safety Monitoring Committee (DSMC) of the EMPHASIS-HF trial confirming the study ... pre-defined stopping rules. , ...
Cached Biology Technology:Secrets of a chiral gold nanocluster unveiled 2Hamilton Thorne partners with Leica Microsystems 2Hamilton Thorne partners with Leica Microsystems 3Hamilton Thorne partners with Leica Microsystems 4Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra® (Eplerenone) 2Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra® (Eplerenone) 3Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra® (Eplerenone) 4Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra® (Eplerenone) 5